Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Innorna today announced the completion of enrollment and vaccination in its Phase II clinical trial for IN the worlds first bivalent respiratory syncytial virus RSV mRNA vaccine currently in development by the company
Cytiva a Danaher company and a global leader in the life sciences industry and WhiteLab Genomics a techbio company specializing in artificial intelligence for genomic medicine research and development
Patients who suffer from chronic conditions often require continuous injections of drugs which is quite painful and often inconvenient To address this researchers from South Korea have developed new wearable microneedles
The Chinese National Medical Products Administration NMPA has approved Tzield teplizumab as the first diseasemodifying therapy in autoimmune type diabetes TD indicated to delay the onset of stage
Evonik a global specialty chemicals company and Ethris a clinicalstage biotechnology company pioneering nextgeneration RNA therapeutics and vaccines have entered into a strategic collaboration
Metabolon Inc the global leader in providing metabolomics solutions advancing a wide variety of life science research diagnostic therapeutic development and precision medicine applications
XtalPi Inc has announced that PEP a nextgeneration PRMT inhibitor candidate developed through its AI drug discovery collaboration with PharmaEngine Inc TWO has received regulatory clearances
A new generics manufacturing facility is set to launch in Southeast Asia aiming to boost local production and supply
A leading pharmaceutical company in Asia has launched an advanced AI system designed to streamline the drug discovery process
NurExone Biologic Inca pioneering biopharmaceutical company developing exosomebased regenerative therapies is pleased to announce that the United States Patent and Trademark Office has issued
